HC Wainwright Reaffirms Buy Rating for Artelo Biosciences (NASDAQ:ARTL)
HC Wainwright reiterated their buy rating on shares of Artelo Biosciences (NASDAQ:ARTL – Free Report) in a report released on Tuesday morning,Benzinga reports. They currently have a $5.00 target price on the stock. A number of other research analysts have also recently commented on the company. LADENBURG THALM/SH SH upgraded Artelo Biosciences to a “strong-buy” […]
